Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac diethylamine 2.32% vs 1.16% in acute ankle sprain
CTR20191620Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac diethylammonium in Ankle sprain, Musculoskeletal pain, soft tissue injury, arthralgia, osteoarthritis (OA), sponsored by Novartis. Started Aug 2019; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
Ankle sprainMusculoskeletal painsoft tissue injuryarthralgiaosteoarthritis (OA)
Beyond the preview
Go deeper on CTR20191620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191620.